To Study The Efficacy Of Sarivadi Kwathpan In Yonikandu

A Single Arm Open Label Clinical Study To Evaluate The Efficacy Of Sarivadi Kwath Orally In Yonikandu - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076892

Enrollment

Registered

2024-11-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N909- Noninflammatory disorder of vulvaand perineum, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patint having symptoms of Yonikandu Controlled blood sugar level

Exclusion criteria

Exclusion criteria: Serologically positive patients Pregnant patients Patients suffering from auto immune disorder like SLE

Design outcomes

Primary

Measure	Time frame
To determine the efficacy of Sarivadi Kwath orally On YonikanduTimepoint: Assessment of Sarivadi Kwath orally on Yonikandu for 3 months	—

Secondary

Measure	Time frame
To determine the efficacy of Sarivadi Kwath orally On YonikanduTimepoint: Assessment of Sarivadi Kwath Orally on Yonikandu for 4 week	—

Countries

India

Contacts

Public ContactDrVaidehi Vasantrao Ayalwar

Ashtang Ayurved Mahavidya Pune

hrj9371@gmail.com919881466344

Outcome results